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Background
To date, there is no consensus on the ideal management strategy of patients with poor
ovarian response (POR) to controlled ovarian stimulation (COS) for in vitro
fertilization (IVF). Currently, these patients are given the choice of: (1) canceling the
cycle; (2) proceeding with COS regardless of the poor response, and performing the
oocyte retrieval and transfer of embryos when available; or (3) conversion to an
intrauterine insemination (IUI). When the decision to proceed with the COS cycle is
taken, it is not clear whether IVF or conversion to IUI is the best choice. If live birth
rates were comparable between the two strategies, conversion to IUI would be the
better option for poor responders, since it is less invasive and is associated with a
lower cost.
Methods
We designed a non-inferiority, multicentric, randomized controlled trial that will be
conducted in 18 French Reproductive Medicine centers. We defined POR as the
presence of only two or four mature follicles ≥ 14 mm on ovulation trigger day.
Patients with POR will be randomized into two parallel arms: “IVF” and “conversion to
IUI.” Our main objective is to compare the efficiency of IVF and conversion to IUI in
patients with POR to COS. The primary outcome is the live birth rate, defined as the
birth of a living infant after 22 weeks’ gestational age, or weighing ≥ 500 g. One of the
secondary objectives is to compare the cost-efficiency of both strategies at 12 months.
We will need to include 940 patients (470 in each arm), and the duration of the
inclusion period is estimated to be 36 months.
Discussion
This is the first randomized controlled trial to compare the outcomes of IVF and
embryo transfer to conversion to IUI in patients with POR to COS. If our study shows
that conversion to IUI is non-inferior to IVF in terms of clinical efficiency and live birth
rate, it would confirm IUI as a better alternative for patients, both individually (less
invasive and more patient-friendly) and collectively (lower cost).
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